This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert L. Bloomfield; Henry S. Miller; Carolyn F. Pedley; Michael J. Colflesh; Sergei Novikov

Arch Intern Med. 1996;156(10):1115-1116.

Abstract
We read, with great interest, the articles and the editorial in your November 13, 1995, issue of the Archives.^1-3 Like so many in your readership, we use a large volume of calcium antagonists in the treatment of our hypertensive patients, particularly those with arrhythmias and angina. We have also listened to Furberg and Psaty³ at various meetings. One issue that all the authors^1-3 should have addressed in more detail in their articles relates to the dose-response differences of these agents. The Treatment of Mild Hypertension Study⁴ is alluded to by Epstein² in regard to comparisons of different antihypertensive agents. However, as the Treatment of Mild Hypertension Study demonstrated, low doses of various classes of pharmacologic agents, as opposed to higher doses, may have differing physiologic effects. Furberg,5 himself, has stated that dose-response differences represent one issue that directed him to the potential problems associated with

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?